SDHB and renal cell carcinoma: Moreover, these suggested careful observations of patients at risk of SDH mutation related renal cell carcinoma and extensive surgical excision of renal tumors   95  and following the genetic consequences, a succession of tyrosine kinase inhibitors was administered as targeted treatment options and obviously showed how the genetic findings make the accessible motivation for their helpfulness96.